Genetron Holdings Stock

Genetron Holdings Liabilities 2024

Genetron Holdings Liabilities

429.2 M CNY

Ticker

GTH

ISIN

US37186H1005

WKN

A2P661

In 2024, Genetron Holdings's total liabilities amounted to 429.2 M CNY, a 37.56% difference from the 312 M CNY total liabilities in the previous year.

Genetron Holdings Aktienanalyse

What does Genetron Holdings do?

Genetron Holdings Ltd is a Chinese company that focuses on the development of discoveries in genomic research. They are known for their advanced technologies that allow for the development of cancer diagnostics and personalized therapies. History: Genetron was founded in 2015 by Sizhen Wang, a leading expert in the field of molecular diagnostics. Since then, the company has experienced rapid growth and has become a well-known name in genomic research. In 2019, Genetron Holdings went public on the Beijing Star Board of the Chinese stock exchange. Business model and divisions: The company is divided into two main activities - diagnostics and research. In the diagnostics division, the company focuses on developing personalized medicines for cancer patients. Genetron works closely with hospitals and research institutions throughout China to develop diagnostic tools for cancer prevention. In the research department, the company is involved in the discovery of new genetic markers for various diseases. Genetron utilizes state-of-the-art technologies such as Crispr-Cas9 to edit genes and determine which genes are responsible for which diseases. Products and services: Genetron offers a range of products and services for cancer diagnostics. One of their most well-known products is the Genetron Health System, a platform for personalized medicine. The system uses genetic profiles to identify the best treatment options for patients. Genetron also offers a variety of other diagnostic tests, including tests for ovarian cancer, lung cancer, and stomach cancer. The company also offers a variety of research services. These include genetic studies, the discovery of new medical therapies, and collaboration with other companies in the field of genomic research. Conclusion: Genetron Holdings Ltd is a company with a fascinating history and a unique business model. Their dedication to innovative cancer diagnostics and personalized medicine has helped them become leaders in genomic research. The company offers a wide range of products and services and works closely with the medical community to improve the health and well-being of patients. Genetron Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Genetron Holdings's Liabilities

Genetron Holdings's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Genetron Holdings's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Genetron Holdings's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Genetron Holdings's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Genetron Holdings’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Genetron Holdings stock

What is the level of liabilities of Genetron Holdings this year?

Genetron Holdings has a debt balance of 429.2 M CNY this year.

What were the liabilities of Genetron Holdings compared to the previous year?

The liabilities of Genetron Holdings have increased by 37.56% increased compared to the previous year.

What are the consequences of high debt for investors of Genetron Holdings?

High liabilities can pose a risk for investors of Genetron Holdings, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Genetron Holdings?

Low liabilities mean that Genetron Holdings has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Genetron Holdings affect the company?

An increase in liabilities of Genetron Holdings can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Genetron Holdings affect the company?

A decrease in the liabilities of Genetron Holdings can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Genetron Holdings?

Some factors that can influence the liabilities of Genetron Holdings include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Genetron Holdings so important for investors?

The liabilities of Genetron Holdings are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Genetron Holdings take to modify the liabilities?

To change its liabilities, Genetron Holdings can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Genetron Holdings pay?

Over the past 12 months, Genetron Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genetron Holdings is expected to pay a dividend of 0 CNY.

What is the dividend yield of Genetron Holdings?

The current dividend yield of Genetron Holdings is .

When does Genetron Holdings pay dividends?

Genetron Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genetron Holdings?

Genetron Holdings paid dividends every year for the past 0 years.

What is the dividend of Genetron Holdings?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genetron Holdings located?

Genetron Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genetron Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genetron Holdings from 8/18/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 8/18/2024.

When did Genetron Holdings pay the last dividend?

The last dividend was paid out on 8/18/2024.

What was the dividend of Genetron Holdings in the year 2023?

In the year 2023, Genetron Holdings distributed 0 CNY as dividends.

In which currency does Genetron Holdings pay out the dividend?

The dividends of Genetron Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genetron Holdings

Our stock analysis for Genetron Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genetron Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.